FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|March 30, 2021
COVID-19 Updates: US and Global Cases, Deaths, and Vaccinations as of March 30, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 28.9% of total US population have received at least 1 dose
• 16.1% of total US population are fully vaccinated
• 16.1% of total US population are fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. New Mexico: 23.2%
2. Alaska: 22.1%
3. South Dakota: 22%
4. Rhode Island: 20.7%
5. North Dakota: 20.2%
2. Alaska: 22.1%
3. South Dakota: 22%
4. Rhode Island: 20.7%
5. North Dakota: 20.2%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 30 349 019 confirmed cases
• 550 165 deaths
• 550 165 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 664 407
2. Texas: 2 786 470
3. Florida: 2 047 379
4. New York: 1 861 491
5. Illinois: 1 239 502
2. Texas: 2 786 470
3. Florida: 2 047 379
4. New York: 1 861 491
5. Illinois: 1 239 502
Deaths: California has the most deaths due to COVID-19 with 59 030 reported fatalities, followed by New York with 50 158, and Texas with 48 135.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 127 880 539 confirmed cases, 2 795 587 deaths, and 72 555 518 recoveries.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.
FDA acceptance starts review of clesrovimab for second-season RSV prevention in high-risk children younger than 2 years.
A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.
Advertisement
Advertisement
Trending on Patient Care Online
1
Lumateperone Reduces Acute Mania Symptoms in Phase 3 Bipolar I Trial
2
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
3
Clinical Inertia and Poor Measurement Technique Undermine BP Control
4
FAQ: What the Endocrine Society’s New Scientific Statement Means for Obesity Treatment
5